Inozyme Pharma, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
Pivotal bioVenture Partners and its affiliates have ceased to be beneficial owners of Inozyme Pharma, Inc. after tendering over 4.49 million shares in a BioMarin Pharmaceutical tender offer.